2 unknown, 1 active not recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Active not recruiting 1, Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Negative control: new trials by email Literature Review of Negative control trials Research Report on Negative control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM). Dapagliflozin (DAPA), Placebo, Negative control - Diabetes Mellitus, Non Alcholic Fatty Liver Disease | Phase 1 / Phase 2 | Active not recruiting | Amira Bisher,PhD | 60 | 2024-01-15 | 2025-06-13 |
| Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis use of basil extract gel in treatment of aphthus ulcer, muco adhesive placebo gel, no treatment - Oral Ulcer | Phase 2 | Unknown | Tanta University | 30 | 2021-01-01 | 2021-07-14 |
| Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC endostar, Placebos, radiotherapy - Non-small Cell Lung Cancer | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 50 | 2017-02-21 | 2018-08-03 |
| KLâ‚„Surfactant Treatment in Patients With ARDS A.1 Lucinactant, B.3 SoC, A.2 Lucinactant - Acute Respiratory Distress Syndrome | Phase 2 | Terminated | Windtree Therapeutics | 124 | 2001-05-01 | 2018-08-09 |
Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1) · Oral Ulcer (1) · Respiratory Distress Syndrome (1) · Stomatitis, Aphthous (1)
Amira Bisher,PhD (1) · Tanta University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Windtree Therapeutics (1)
Egypt (2) · China (1) · United States (1)